Shanwan Biotech
Latest round
- Series B
Last raised
- Apr 2025
Total raised
- Undisclosed
Investors
- 1
About Shanwan Biotech
Founded in 2018 and based in Suzhou, China, Shanwan Biotech has concentrated on innovative long-acting and controlled-release drug formulations. Leveraging its location in the Yangtze River Delta, the company has built a foundation that combines in-house drug development with third-party formulation services, gradually expanding its presence in the biopharmaceutical sector. Shanwan Biotech develops and manufactures advanced sustained-release injectable formulations, with in-situ gel technology as its core platform. In addition to its proprietary drug pipeline, the company also provides contract development and manufacturing (CDMO) services, supporting other pharmaceutical firms with formulation innovation, process development, and production. The company generates revenue from the development, manufacturing, and sales of its pharmaceutical products, as well as from CDMO services offered to external partners.
Who invested in Shanwan Biotech
1 investor across 1 round
See all investors in Shanwan Biotech
Sign up free to see every VC on the cap table, the rounds they joined, and how much each round raised.
Funding rounds
Series B
Apr 23, 2025
Amount
Undisclosed
Investors
Questions about Shanwan Biotech
Who invested in Shanwan Biotech?
Shanwan Biotech has 1 investor on record across 1 venture round. Sign up free to see every VC on the cap table and the rounds they joined.
How much funding has Shanwan Biotech raised?
Shanwan Biotech has raised 1 venture round. Sign up free to see how much each round raised and the total.
When did Shanwan Biotech last raise money?
Shanwan Biotech's most recent round on record is a Series B, in Apr 2025.
What does Shanwan Biotech do?
Founded in 2018 and based in Suzhou, China, Shanwan Biotech has concentrated on innovative long-acting and controlled-release drug formulations.
Where is Shanwan Biotech headquartered?
Shanwan Biotech is headquartered in Suzhou, China.
Which VCs invest in companies like Shanwan Biotech?
Among active investors with capital left to deploy, Shanghai State-owned Capital Investment Leading Fund, Yufu Capital, ICBC Capital Management and Ningbo Tongshang Fund back biotechnology companies at Shanwan Biotech's stage. Their profiles are linked below.
VCs backing biotechnology startups at Series B
Raising like Shanwan Biotech? Find the right VCs.
Capital Atlas matches your startup to active investors by stage, sector and region.